Bone ingrowth to implant surfaces in an inflammatory arthritis model.
Many studies have shown enhanced bone apposition to implants coated with hydroxyapatite, but the optimum implant texture, especially in abnormal trabecular bone, is unclear. The purpose of this project was to evaluate the histological and mechanical properties of cylindrical implants with three different surface textures that were placed in the cancellous bone of the distal femur of the rabbit after the production of an inflammatory knee arthritis. The three implant surfaces included a beaded surface (Group A), a beaded surface coated with hydroxyapatite (Group B), and a smooth surface coated with hydroxyapatite (Group C). The right knees of 36 rabbits were injected with carrageenan twice a week for 2 weeks. Then bilateral implantations were performed, with 12 rabbits in each group receiving identical implants in the right and left knees. The rabbits were killed 6 weeks after surgery. Mechanical (push-out test) and histomorphometric analyses were performed to determine the quality and quantity of bone ingrowth. In Group A, there was virtually no direct contact (a 20-60-microm clearance) between the bone and the beaded surfaces. Direct contact between the bone and the implant surfaces was seen in Groups B and C. The thickness and number of trabeculae were smaller on the arthritic side than on the control side for all groups but were not different between groups for either the control or the arthritic side. Mechanical testing showed that the shear strength of the interface was weaker on the arthritic side in all groups. The results suggest that inflammatory arthritis induced by carrageenan may influence the quality of local bone (osteopenic changes) and hence compromise the bone apposition and mechanical stability of the interface between the implant and bone.
An
Y H
YH
Department of Orthopaedic Surgery, Medical University of South Carolina, Charleston 29425, USA.
Friedman
R J
RJ
Jiang
M
M
LaBreck
J C
JC
Draughn
R A
RA
Butehorn
H F
HF
Bauer
T W
TW
D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000276:immunology* / Q000601:surgery*; D001851:Bone Diseases, Metabolic / Q000276:immunology / Q000601:surgery; D002351:Carrageenan; D017886:Durapatite; D005079:Excipients; D005269:Femur / Q000502:physiology / Q000601:surgery*; D008297:Male; D008422:Materials Testing; D016348:Osseointegration / Q000502:physiology*; D019736:Prostheses and Implants; D011817:Rabbits; D013314:Stress, Mechanical; D013583:Synovial Membrane / Q000276:immunology; D013977:Tibia / Q000503:physiopathology / Q000601:surgery; D016474:Weight-Bearing / Q000502:physiology
D005079:Excipients; D002351:Carrageenan; D017886:Durapatite